Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. However, genome wide association studies (GWAS) of the more common (~90%) sporadic form have been less successful with the exception of the replicated locus at 9p21.2.
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ABSTRACT
Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. However, genome wide association studies (GWAS) of the more common (~90%) sporadic form have been less successful with the exception of the replicated locus at 9p21.2.
To identify new loci associated with disease susceptibility we have established the largest association study in ALS to date and undertaken a GWAS meta-analytical study combining (the International Consortium on Amyotrophic Lateral Sclerosis Genetics). We analyzed a total of 13,225 individuals, 6,100 cases and 7,125 controls for almost 7 million single nucleotide polymorphisms (SNPs). We identified a novel locus with genome-wide significance at 17q11.2 (rs34517613 P = 1.11 x 10 -8 ; OR 0.82) that was validated when combined with genotype data from a replication cohort (P = 8.62 x 10 -9 ; OR 0.833) of 4,656
individuals. Furthermore, we confirmed the previously reported association at 9p21.2 (rs3849943 with P = 7.69 x 10 -9 ; OR 1.16). Finally, we have estimated the contribution of common variation to heritability of sporadic ALS as ~12% using a linear mixed model accounting for all SNPs. Our results provide an insight into the genetic structure of sporadic ALS, confirming that common variation contributes to risk and that sufficiently powered studies can identify novel susceptibility loci.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a late onset progressive neurodegenerative disorder mainly affecting motor neurons. ALS is the most common adult onset motor neuron disease with prevalence of 5 per 100,000 and with family history, age and male gender as the major risk factors (1) (2) (3) (4) . While familial ALS is well characterized with several causative genes identified to date, the genetic architecture of the more common sporadic form is poorly understood. Previous GWAS have identified several loci associated with ALS risk such as DPP6, ITPR2, FGGY and UNC13a (5-11) that have failed to be replicated in independent populations (12-15). One exception is a locus on chromosome 9p21 (15) that has been reliably replicated (16) . At this locus an expanded hexanucleotide repeat in the C9orf72 gene has been recently identified as the causative mutation in a large proportion of familial (23-47%) as well as sporadic (~5%) ALS cases (17) (18) (19) (20) . This finding indicates that well powered studies can identify novel loci associated with ALS susceptibility. To discover further loci we designed a large GWAS meta-analysis with sufficient power to detect risk alleles with small effect sizes as observed in other neurodegenerative and complex diseases. There is evidence for a strong genetic component in sporadic ALS with heritability estimated to be 0.61 (95% CI: 0.38-0.78) in a combined study of 171 ALS twin pairs collected by three independent studies from Britain and Sweden (21), so we sought to estimate heritability derived from unrelated individuals and explained by common variation using GWAS data. Phenotype variation in complex traits is due to interactions of genetic and environmental factors, thus the quantification of the genetic variance is relevant in the study of multifactorial diseases.
Heritability, the proportion of phenotype explained by genetic variance, is typically estimated in close related individuals such as twin pairs but this can inflate estimates as a consequence of epistatic interactions or shared environment (22, 23) . In contrast, heritability explained by associated SNPs identified in GWAS as passing accepted thresholds of significance (typically The difference between the phenotypic variance explained by GWAS results and those estimated in family studies is referred to as the "missing heritability problem" and possibly is explained by incomplete linkage disequilibrium (LD) between genotyped SNPs and causal variants and/or by the presence of gene-by-gene or gene-by-environment interactions (22, 23) .
We have estimated heritability of ALS considering all SNPs simultaneously regardless of their association with ALS phenotype and compared this with heritability from twin studies.
RESULTS
Association analyses
We analyzed genotype raw data from eight independent studies including 3,959 newly genotyped Italian individuals (1,982 cases, 1,977 controls) and 11,611 individuals (5, 195 cases and 6,416 controls) from previously published studies. Full description of the sample size included in this study is reported in Table 1 and Supplementary Table S1 .
Raw data for each study were assessed for quality control (QC) separately following the same criteria (see Supplementary Material and Supplementary Table S2 for full discussion).
Population structure of the individual cohorts was studied by means of principal components analysis (PCA) with EIGENSTRAT software (24, 25) and outliers were identified by the projection of the first 10 principal components (Methods, Supplementary Material, Supplementary Fig. S1 ).
To achieve the maximal coverage we imputed genome-wide filtered originally genotyped data for each study (Methods). Overall the average number of inferred genotypes was 8,342,920
SNPs varying proportionally to the original genotyping platform. After filtering (Methods, Supplementary Material), the eight data sets included genotype data for almost 7 million SNPs 8 in 13,225 individuals (6,100 cases and 7,125 controls) (Supplementary Table S2) . Cleaned imputed genotypes were tested for association with ALS separately using SNPTESTv2.4.0 (26) and the logistic regression analyses were adjusted by the appropriate principal component axes estimated in the individual cohorts (Supplementary Table S3 ). After genomic inflation control, we combined the logistic regression analysis results of each study in a meta-analysis using the program METAL (27) . We adopted the "standard error" analysis scheme which combines effect size estimates (β-coefficients) across the studies weighted according to the inverse of the corresponding standard errors. As a result of the meta-analysis we observed two loci reaching genome wide threshold of significance, rs3849943 P = 7.69 x 10 -9 (OR 1.16, 95% CI: 1.10- Fig. 1, Fig. 2 , Supplementary Fig. S2 ). With the exception of the locus on 9p21, loci previously found to be associated with ALS risk (5-11) did not reach genome wide significance in our meta-analysis (Supplementary Table S4 ) though SNP rs12608932 (UNC13A) at 19p13.3
had not complete coverage across datasets as it failed the QC threshold in the British data set ( Supplementary Fig. S3 ). Additionally, examination of these previously associated loci in the Italian cohort as an independent replication study only found evidence for association for the 9p21 locus, and for the ITPR2 locus while significant, direction of effect is the opposite to that reported in the original study (8) (Supplementary Fig S3) . Only the ITPR2 locus showed significant evidence for heterogeneity across the different cohorts of European ancestry analyzed here (Supplementary Table S5 ). Further larger studies are needed to confirm the role of these loci in ALS susceptibility.
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As inclusion of non-confounding covariates such as gender and age can significantly reduce power to identify truly associated variants particularly when the disease prevalence is low (< 1%), we have not included non-confounding covariates in logistic regression analyses presented here (28) . In confirmation of our approach, the most significant SNPs (P ≤ 1 x 10 -5 ) mapping in the two candidate loci at 17q and 18q showed no gender-by-SNP interaction in multi regression analysis (Methods).
For these loci we searched for secondary signals by performing logistic regression conditioning upon the most associated SNPs under an additive model. There was no evidence of independent SNPs in any of these regions (Supplementary Table S6 ). As the international meta-analysis included samples from Northern and Southern Europe, we tested the most associated SNPs for genetic heterogeneity quantifying the effect of the degree of variation between studies (Methods, Supplementary Material). We observed no significant heterogeneity in the distribution of allele frequencies between European populations for these SNPs (Supplementary Table S7 ).
As additional evidence, we tested the candidate loci at 17q and 18q in a novel independent replication cohort of 2,074 cases and 2,556 controls collected in Italy, Netherlands and
Germany (see full description in the Methods, Supplementary Material and Supplementary Table S8) . For each locus, we selected two variants, the most associated in the GWAS metaanalysis (imputed data) and combined joint analysis (original genotype data) (Supplementary Material, Supplementary Table S9 ). We found suggestive evidence for association in the independent replica analysis for SNP rs34517613 at 17q (P = 0.055; OR 0.89, 95% CI: 1.00-0.78) and when combined in meta-analysis with the full GWAS data the association identified in the discovery sample became more significant (P combined = 8.62 x 10 -9 ; OR 0.833, 95% CI:
0.891-0.778). We found no additional evidence for association at the 18q11.2 locus (Supplementary Table S10 ). Fig. 2 ).
Next, we looked for cis eQTL (expression quantitative trait loci) in LD with our lead SNPs.
All SNPs in LD (r 2 ≥ 0.2) with rs34517613 and rs1788776 were analyzed for association with cis eQTL using several publicly available eQTL databases (Supplementary Material) but none reached the P-value threshold for significance. This should be not considered conclusive as expression data from central nervous system tissues are still rather limited across eQTL databases and further studies should be carried out.
Contribution of C9orf72 to chromosome 9p21 association signal
As chromosome 9p21 was found to be strongly associated in our meta-analysis, we further investigated the contribution of ALS sporadic cases that also carry the expanded hexanucleotide repeat in the C9orf72 gene to this association. Information about carriers of the pathologic expansion in C9orf72 gene was available for 2,287 out of 6,100 (37.3%) ALS cases from the Italian, Dutch and British studies included in the meta-analysis. The frequency of the expanded repeats carriers in the sporadic cases we have analyzed progressively decreased as you proceed from Northern to Southern Europe ranging from 8% to 4.7% respectively in the British and Italian patients (Methods, Supplementary Table S10). Our results confirm data previously reported (17) (18) (19) (20) . We performed a meta-analysis of this sample subset (2,287 sporadic cases, 4,162 controls) including and excluding cases (n=144) with the expanded hexanucleotide repeat. Significant association of SNP rs3849943 decreased from P = 7.72 x 10 -5 to P = 0.052 when the carriers were excluded from the logistic regression analysis confirming that the association of 9p21 locus was largely dependent on carriers of the C9orf72 expansion ( Supplementary Fig. S4 ).
Heritability estimation
We used the Genome-wide Complex Trait Analysis (GCTA) method (29) to quantify additive genetic variance (narrow sense heritability) explained by all common SNPs regardless of their association with disease. GCTA uses a linear mixed-effect model that includes a random effect to estimate the polygenic component of trait variation (29) . We performed GCTA analysis on 13,225 individuals (6,100 ALS cases and 7,125 controls) whose pair wise relationship was estimated to be less than 0.05 (PI_HAT) and used a restricted maximum likelihood (REML) algorithm to estimate the variance explained by imputed SNPs data. Analyses were carried out separately in the eight cohorts using a more stringent quality control threshold for imputed SNPs (MAF > 0.01, posterior probability > 0.9 and information measure > 0.8) (Methods, Supplementary Material Table S2 ) under the assumption of an ALS prevalence of 5 per 100,000.
Heritability estimates were similar (~11.5%) for all cohorts (Supplementary Table S12 ) and were combined in meta-analysis modelled for random effects and weighted by sample size. The summary heritability was 0.119 (95% CI: 0.110-0.127) (Fig. 3) .
Exclusion of the chromosome 9p21 locus did not affect heritability estimates. As ALS is a disease of aging and age is increasing in the human population, an increase in the prevalence of 12 ALS can be predicted. Consequentially the true prevalence of ALS may be higher than that used in our analysis. We have therefore calculated heritability over a range of prevalences, but for all prevalences estimation of heritability attributable to common variation does not exceed 0.25
( Supplementary Fig. S5 ).
DISCUSSION
In this study we present the largest GWAS meta-analysis to date in ALS. Overall we analyzed 13,225 individuals with sufficient power to capture allelic association with small effects and low MAF. The novel associated SNP rs34517613 at 17q11.2 was confirmed when genotype data from the independent replication cohort were combined in meta-analysis with full GWAS data. We have also replicated the 9p21 locus at genome wide significance; this locus was also identified by linkage studies of familial ALS patients and by analogy it may be that there is a corresponding familial locus for the 17q11.2 locus identified here, though we are not aware of any reports.
The lead SNP at this locus was in LD with three SNPs in the SARM1 gene. Interestingly, SARM1 orthologues, dSarm in Drosophila melanogaster and Sarm1 in mice, have been recently found to play a direct role in an axonal self-destruction pathway, a mechanism known as Wallerian degeneration which shares morphological similarities with the axon dying-back degeneration observed in ALS and in other neurodegenerative pathologies (30, 31) . As axonal degeneration is an early feature of ALS progression, a mouse model for familial ALS, SOD1G93A, was crossed with the Wld S mouse, a spontaneous mutant with phenotype of prolonged survival of injured axons due to a chromosomal rearrangement that disrupts two genes, Ube4b and Nmnat1. In the SOD1G93A/Wld S the progression of axonopathies was attenuated suggesting that the Wallerian pathway could be involved in the axon loss observed in ALS (32, 33) . We estimated the heritability of ALS due to common variation as ~12% based on a prevalence of 5 per 100,000 (1,2), although the true prevalence of ALS may be higher as consequence of increasing age in the human population as discussed above. We have also only considered autosomal SNPs and additional variance may be encoded on the X chromosome. Twin studies estimate heritability due to all genetic variation including rare monogenic forms of the disease whilst we have estimated heritability as a consequence of common polymorphisms either directly typed or imputed. The difference between heritability estimated from twin studies and from analysis of common SNP polygenic variation suggests a substantial role for variation not captured by genome wide association studies.
Our estimate for the heritability of ALS due to common variation is lower than that for other late-onset neurodegenerative diseases. Using similar approaches, heritability for late-onset Alzheimer's disease with a similar sized stage 1 sample identified two loci additional to the well replicated APOE locus (37) . In comparison to these studies our combined sample size is more than 13,000 individuals suggesting that the genetic architecture of ALS may be different from other more common neurodegenerative diseases. A recent study of ALS in a Han Chinese population identified two loci of genome wide significance in a combined sample of around 5,000 (38) ; strikingly these loci were not replicated in populations of European ancestry, nor in the combined meta-analysis reported here. This suggests there may be considerable heterogeneity in ALS risk loci across different ethnicities, in support of this, the expanded repeat in the C9orf72 gene has been reported to be infrequent in Asian populations (39, 40) .
In conclusion, we have identified a novel locus for sporadic ALS risk at 17q11.2, but not replicated the suggestive evidence for a second locus at 18q11.2 and confirmed the association at 9p21 with the expanded hexanucleotide repeat in the C9orf72 gene. Furthermore we provide evidence from our heritability estimates that further common variation affecting ALS risk remains to be detected by current GWAS platforms and with larger cohorts but that denser genome wide assays and next generation sequencing technologies are required to detect rarer variation.
MATERIALS AND METHODS
Participating individuals
The discovery sample consisted of a novel Italian cohort collected by the Italian Consortium for the Genetics of ALS (SLAGEN) and seven independent published studies collected by 
Genotyping Procedures
Samples from the individual cohorts were genotyped on different Illumina beadchips (Illumina, CA, USA) as shown in Table 1 
Statistical analysis
Quality control and meta-analysis of imputed data
Before imputation analysis quality control (QC) of samples and markers were performed separately in the eight studies using the PLINK software package (42) . A detailed description of QC procedure is reported in the Supplementary Material and Supplementary Table S2 .
Genotype data from British cases and controls were merged and analyzed as single cohort as fully described in the Supplementary Material and Supplementary Table S2 .
Ancestry differences between individuals within each cohort were detected by principal components analysis (PCA). Principal component axes were generated by genotypes of a genome wide subset of LD independent SNPs using EIGENSTRAT software (24, 25) Fig. S1 ). As an example, Supplementary Figure S5 shows the population structure of the novel Italian cohort by the projection of the first two PC axes.
After quality control, original genotype data of each study were tested for genomic inflation and lambda estimates resulted to be minimal (λ (gc) < 1.02). Individual datasets were imputed genome wide separately using the IMPUTE.v2 program (43, 44) Table   S2 ). Finally, filtered SNP tables were combined in a meta-analysis and analyzed with the program METAL (27) , applying the standard error scheme option that weights effect size estimates, or β-coefficients, using the inverse of the corresponding standard errors. The zscores were calculated from the P values of each study with the sign of the z-scores indicating the direction of allelic effect in that study (z > 0 for odds ratio > 1). Meta-analysis was performed applying the fixed-effects model that does not account for between study heterogeneity, therefore heterogeneity was quantified by the Cochran's statistic (Q) and I (METAL). P values were estimated by comparing the statistic with a X 2 distribution (N-1 degrees of freedom, N= number of studies) (Supplementary Material, Supplementary Table   S5 and S7) (45, 46) . Meta-analysis was repeated stratifying by gender and testing for the gender-by-SNP interaction as described in the Supplementary Material.
For the independent replication cohort logistic regression analyses (SNPTESTv2.4.0) were performed separately in the Italian, Dutch and German samples and then combined in metaanalysis (METAL) applying standard error scheme as described above. Next, statistic tables of the three novel replication samples were combined with the discovery sample in a final meta-analysis (METAL).
Power calculation
The final meta-analysis cohort had 99.99% power to detect allelic association with an odds Fig. S8 ).
Screening of expanded repeats in C9orf72 gene
Hexanucleotide repeat expansion data for the C9orf72 gene were available for the Italian, Dutch and British cases (Supplementary Table S10 ). As previously reported carriers were defined as individuals with a range of the GGGGCC repeats larger than 23 units (17) (18) (19) (20) . We performed conditional logistic regression analysis on a subset of 2,287 screened cases and 4,162 controls including and excluding pathologic expansions carriers (n=144). 
Estimation of the genetic variance tagged by all SNPs
We used GCTA (Genome-wide Complex Trait Analysis) software (29) to estimate the proportion of ALS phenotypic variance explained by autosomal SNPs distributed genome wide. Genetic relationships between pairs of individuals were calculated separately in the eight cohorts where all samples were previously tested for cryptic relatedness and excluded if the proportion of IBD (identical-by-descent) estimate was larger than 0.05 (Supplementary Table S2 ). We estimated the genetic relationship matrix (GRM) including imputed genotypes filtered by MAF > 0.01, posterior probability > 0.9 and information measure > 0.8. Filtered genotype data were submitted to GRM analysis and GRMs output data were used in the restricted maximum likelihood (REML) analysis. In each data set REML analysis was carried out by fitting the specific principal components (Supplementary Table S3 
TABLES
